CN Patent
CN113559079B — 一种软胶囊及其制备方法和用途
Assigned to Jiangsu Hengrui Medicine Co Ltd · Expires 2023-10-20 · 3y expired
What this patent protects
本公开具体涉及一种软胶囊及其制备方法和用途。具体而言,公开的软胶囊其包含ω‑3脂肪酸,具体涉及高纯度的二十碳五烯酸乙酯。制备该软胶囊的胶囊壳包含B型明胶以及甘油、山梨醇增塑剂,制备得到的软胶囊具有良好的稳定性和崩解性能,适合工业化生产且具有较高的临床应用价值。
USPTO Abstract
本公开具体涉及一种软胶囊及其制备方法和用途。具体而言,公开的软胶囊其包含ω‑3脂肪酸,具体涉及高纯度的二十碳五烯酸乙酯。制备该软胶囊的胶囊壳包含B型明胶以及甘油、山梨醇增塑剂,制备得到的软胶囊具有良好的稳定性和崩解性能,适合工业化生产且具有较高的临床应用价值。
Drugs covered by this patent
- Epanova (OMEGA-3-CARBOXYLIC ACIDS) · AstraZeneca
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.